Dactilus

Oral hypoglycemic agent. Highly potent, selective and reversible inhibitor of sodium–glucose cotransporter 2 (SGLT2). Indicated for the treatment of type 2 diabetes (T2D).

Therapeutic Area
Oral Antidiabetics + Oral Hypoglycemic

Active Ingredient
Daplagliflozin

Line
Cardiometabolism + Diabetes + Endocrinology + Medical Clinic

Dosage forms
10 mg x 28 coated tablets

Download Leaflet Descargar